CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

The U.S. government is going to pay a lot more for Covid-19 booster shots than it used to, and one Senator from Vermont is not happy about it. The read more, check out the full story at STAT: <a ...

According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...